2.
纳入的NSCLC EGFR扩增研究
Eligible studies for EGFR amplification of NSCLC
| EGFR amplification | Pairs | Primary NSCLC | Metastases | Inconsistency | |||||
| n | Percent | n | Percent | n | Percent | ||||
| Italiano A[23] | 30 | 16 | 53.33% | 12 | 40.00% | 7 | 23.33% | ||
| Bozzetti C[24] | 28 | 10 | 35.71% | 17 | 60.71% | 9 | 32.14% | ||
| Daniele L[15] | 35 | 10 | 28.57% | 16 | 45.71% | 8 | 22.86% | ||
| Monaco SE[25] | 40 | 3 | 7.50% | 8 | 20.00% | 11 | 27.50% | ||
| Sum | 133 | 39 | 28.67% | 53 | 38.97% | 35 | 27.07% | ||